This episode tries out a different format from our regularly scheduled programming. We sit down and discuss (and sometimes rant about) our thoughts about Gilead's $3k price tag announcement for remdesivir. What was supposed to be a quick discussion of a current event quickly devolved into broader discussions about drug pricing, patent law, and public opinion.   email: <a href= "mailto:econrxpodcast@gmail.com">econrxpodcast@gmail.com</a> Twitter/Instagram: @EconRx LinkedIn: <a href= "http://www.linkedin.com/company/econrx">www.linkedin.com/company/econrx</a>

Kiddie Pool Health Insurance

In this show we dive into the business of the US healthcare system. Why are some of my medications covered by insurance but not others? What does it mean for a provider to be "in-network?" Above all, WHERE DO OUR HEALTHCARE DOLLARS GO??! We want to understand and answer these questions, and we want you to come with us on this journey.